跳至主要内容
临床试验/NCT05644483
NCT05644483已完成4 期

Effect of Remimazolam-remifentanil Versus Propofol-remifentanil Based General Anesthesia on Intraoperative Hemodynamic Stability in Prone Position for Major Spine Surgery: a Randomized Controlled Trial

Asan Medical Center1 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2022年3月29日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
94
试验地点
1
主要终点
the number of hypotensive episode per patient

研究概览

简要总结

Most of the major spinal surgeries are performed in the supine position, which causes a decrease in stroke volume and cardiac index, which leads to the occurrence of hypotension during surgery. Postoperative hypotension causes an imbalance in the supply and demand of oxygen, leading to postoperative myocardial infarction or acute renal damage, and may increase mortality one year after surgery. Propofol, which is most commonly used for total intravenous anesthesia, can further increase the incidence of hypotension during surgery. Therefore, there is a continuing demand for an anesthetic agent that is more hemodynamically stable. Remimazolam, an ultra-short acting benzodiazepine that has a similar structure to midazolam, but whose activity is terminated by esterase hydrolysis, is expected to have less hemodynamic effects than propofol. Therefore, the purpose of this study is to investigate the effect of general anesthesia using remimazolam and general anesthesia using propofol on hemodynamic safety during surgery in patients undergoing major spinal surgery in the supine position.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
19 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA physical status: 1-3
  • age: 19-80 years
  • patients who are scheduled to undergo a major spine surgery in the prone position

排除标准

  • patients who refuse to participate
  • body mass index: <15kg/m2 or >35kg/m2
  • patients with uncontrolled hypertension, hyperthyroidism, severe cardiac disease
  • patients who are contraindicated to the use of remimazolam including severe hepatic disease, acute glaucoma, shock, acute alcohol intoxication
  • allergic to propofol and midazolam
  • patients who are judged unsuitable to participate in the study for other reasons by medical staffs

研究组 & 干预措施

remimazolam group

Experimental

patients who receive remimazolam-remifentanil based total intravenous anesthesia

干预措施: Remimazolam (Drug)

propofol group

Active Comparator

patients who receive propofol-remifentanil based total intravenous anesthesia

干预措施: Propofol (Drug)

结局指标

主要结局

the number of hypotensive episode per patient

时间窗: for one hour after turning the patients to the prone position

SAP \< baseline SBP \* 80% or 90mmHg // MAP \< baseline MAP \* 80% or 65mmHg

the number of severe hypotensive episode per patient

时间窗: for one hour after turning the patients to the prone position

SAP \< baseline SBP \* 70% or 80mmHg // MAP \< baseline MAP \* 70% or 55mmHg

次要结局

  • heart rate(for one hour after turning the patients to the prone position)
  • cardiac output(for one hour after turning the patients to the prone position)
  • Total opioid consumption(for one hour after turning the patients to the prone position)
  • pleth variability index(for one hour after turning the patients to the prone position)
  • stroke volume(for one hour after turning the patients to the prone position)
  • cardiac index(for one hour after turning the patients to the prone position)
  • stroke volume variation(for one hour after turning the patients to the prone position)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hajung Kim

Clinical Assistant Professor

Asan Medical Center

研究点 (1)

Loading locations...

相似试验